ArticleRSC advances2025

From silico to benchtop: cosmosiin as a PD-1/PDL-1 immune checkpoint inhibitor revealed through DFT, network pharmacology analysis, and molecular docking integrated experimental verification.

Reem I Alsantali et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.